Kim Hyoun-Ah, Nam Jin-Young, Jung Ju-Yang, Bae Chang-Bum, An Jeong-Mi, Jeon Ja-Young, Kim Bong-Sik, Suh Chang-Hee
Department of Rheumatology, Ajou University School of Medicine, San 5, Wonchon-dong, Yeongtong-gu, Suwon, 443-721, South Korea.
Clin Rheumatol. 2014 Jun;33(6):865-8. doi: 10.1007/s10067-014-2629-8. Epub 2014 Apr 27.
We investigated the growth arrest-specific protein 6 in adult-onset Still's disease. Serums were collected from 52 adult-onset Still's disease patients with follow-up samples of 21 patients. The growth arrest-specific protein 6 levels in adult-onset Still's disease were higher compared to those in the normal controls (25.37±7.71 vs. 19.86±5.01 ng/mL, p<0.001). However, growth arrest-specific protein 6 did not correlate with disease activity. Also, growth arrest-specific protein 6 was not decreased after activity was resolved in the follow-up. The growth arrest-specific protein 6 in adult-onset Still's disease patients were higher than the normal controls. However, growth arrest-specific protein 6 was not correlated with disease activity.
